KAI-9531
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for KAI-9531, covering 2025-12-05 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes [Phase 2]